Cartesian Therapeutics (RNAC) Interest Coverage Ratio (QoQ) (2015 - 2023)
Powered by 
Analysis
Cartesian Therapeutics (RNAC) Interest Coverage Ratio (QoQ) (2015 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Cartesian Therapeutics | 271.98 Mn | 271.98 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 58.59% |
| Jun 30, 2023 | -8.95% |
| Mar 31, 2023 | -116.08% |
| Dec 31, 2022 | -428.04% |
| Sep 30, 2022 | -110.29% |
| Jun 30, 2022 | 27.22% |
| Mar 31, 2022 | 165.67% |
| Dec 31, 2021 | 307.11% |
| Sep 30, 2021 | -535.62% |
| Jun 30, 2021 | 106.31% |
| Mar 31, 2021 | 9.11% |
| Dec 31, 2020 | 70.56% |
| Sep 30, 2020 | 52.87% |
| Jun 30, 2020 | -15.80% |
| Mar 31, 2020 | -83.74% |
| Dec 31, 2019 | -23.44% |
| Sep 30, 2019 | 25.11% |
| Jun 30, 2019 | -35.57% |
| Mar 31, 2019 | 18.44% |
| Dec 31, 2018 | 11.58% |